相关实验视频

Updated: Jun 13, 2025

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

从黑色素瘤中转移转移的治疗治疗选择

Francesco Russano¹, Marco Rastrelli^1,2, Luigi Dall'Olmo^1,2

¹Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padova, Italy.

|September 14, 2024

概括

有效治疗过境黑色素瘤转移 (ITM) 需要将全身疗法与局部区域治疗相结合. 这种综合方法改善了晚期黑色素瘤患者的生存率和生活质量.

科学领域:

在瘤学瘤学.
皮肤病学皮肤病学
医学研究医学研究

背景情况:

黑色素瘤的转移性转移 (ITM) 是由于疾病的晚期而造成的重大临床挑战.
传统的手术切除已经被系统疗法增强,包括免疫检查点抑制剂和向疗法,改善生存率.

研究的目的:

审查和强调黑色素瘤系统和局部治疗模式的有效性.
评估现代疗法对患者治疗结果的综合影响.

主要方法:

临床研究的综合文献综述.
分析包括免疫检查点抑制剂,向疗法,隔离四肢输液 (ILP) 和电化学疗法 (EC) 在内的治疗方法.

主要成果:

系统疗法与局部治疗的结合显著提高了本地疾病控制和整体生存率.
现代免疫疗法补充,而不是减少,当同时使用时,局部区域疗法的有效性.

结论:

综合系统和局部治疗的多学科方法是优化黑色素瘤ITM管理的有希望的策略.
这种综合模型提高了生存率,提高了患者的生活质量,表明了标准护理的潜在转变.

关键词:

隔离四肢输血隔离四肢输血电化学疗法电化学疗法免疫检查点抑制剂免疫检查点抑制剂在过境转移的转移.黑色素瘤是一种黑色素瘤.手术手术手术手术手术手术手术

更多相关视频

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.